SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-α
- 30 June 2000
- journal article
- Published by Elsevier BV in Cytokine
- Vol. 12 (6), 682-687
- https://doi.org/10.1006/cyto.1999.0616
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.JCI Insight, 1997
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsThe Journal of Experimental Medicine, 1997
- CIRCULATING SERUM LEVELS OF IL-1ra IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS ARE NORMAL DURING REMISSION PHASES BUT SIGNIFICANTLY INCREASED EITHER DURING EXACERBATIONS OR IN RESPONSE TO IFN-β TREATMENTCytokine, 1996
- Animal models of human disease Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating diseaseClinical Immunology and Immunopathology, 1995
- Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple SclerosisImmunological Reviews, 1995
- Decreased CD3‐mediated interferon‐γ production in relapsing‐remitting multiple sclerosisAnnals of Neurology, 1995
- Cytokines and natural regulators of cytokinesImmunology Letters, 1994
- Interleukin‐10 prevents experimental allergic encephalomyelitis in ratsEuropean Journal of Immunology, 1994
- INTERLEUKIN-2 RECEPTOR LEVELS INDICATING RELAPSE IN MULTIPLE SCLEROSISThe Lancet, 1989
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983